Tier 2 Professors

undefined

ZHOU Zengtong

Email: zhouzengtong@hotmail.com

Tel: 021-

Research Interests: Integrative study of oral mucosal diseases by traditional Chinese and Western medicine

Biography

  • Individual resume

  • Second-class professor of Shanghai Jiao Tong University, doctoral supervisor, tenured professor and chief physician of Shanghai Ninth People's Hospital, won the title of "People's Famous Doctor · Outstanding Achievements". Long engaged in the cooperation of Chinese and western medicine diagnosis and treatment of oral mucosal disease, as the first director of the Chinese Stomatological Association combine traditional Chinese and western medicine committee and the third director of the Chinese Stomatological Association oral mucosal diseases committee, the first and second session of Shanghai Stomatological Association President, national key specialty and the state administration of traditional Chinese medicine of clinical key specialty academic leaders. Director of Shanghai Stomatological Medical Quality Control Center, Standing Director of Shanghai Council of Integrated Traditional Chinese and Western Medicine. Chief editor and Deputy Chief editor of the National planning textbooks . The first accomplisher won 6 scientific and technological achievement awards, including the second prize of Science and Technology Award of Chinese Stomatological Association, the third prize of Shanghai Science and Technology Progress Award, and the third prize of Science and Technology Award of China Association of Traditional Chinese Medicine. As the first author and corresponding author, he has published more than 200 scientific research papers.

Publications

  1. Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu LQ, Zhou ZT*. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia. Int J Cancer. 2013; 132:868-74.

  2. Wei J, Xie G, Ge S, Qiu S, Liu W, Lu A, Chen T, Li H, Zhou Z*, Jia W. Metabolic Transformation of DMBA-Induced Carcinogenesis and Inhibitory Effect of Salvianolic Acid B and Breviscapine Treatment. J Proteome Res 2012;11:1302−16.

  3. Xie G, Chen T, Qiu Y, Shi P, Zheng X, Su M, Zhao A, Zhou Z*, Jia W. Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics 2012; 8:220-31.

  4. Liu W, Feng JQ, Shen XM, Wang HY, Liu Y, Zhou ZT*. Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: A long-term follow-up study. Cancer. 2012;118:1693-700.

  5. Wei J, Xie G, Zhou Z*, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W. Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 2011;129:2207-17.